
|Articles|January 20, 0008
Inhaled ciclesonide given nod by FDA
Alvesco approved for asthma
Advertisement
Prodrug ciclesonide, activated by intracellular esterases following oral inhalation, has been approved by the FDA as an inhalation aerosol for use as a prophylactic therapy in adults and adolescents aged 12 years and older with asthma. The drug is called a new generation of corticosteroid by manufacturer
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Enflonsia for the Prevention of RSV Lower Respiratory Tract Disease in Infants
2
The Emergence of CGRP-Targeted Therapies is Transforming Migraine Care | NCPA 2025
3
Pharmacists Experience Challenges in Credentialing, Billing for Services | NCPA 2025
4
FDA Approves Tezepelumab for as Add-On Treatment for Chronic Rhinosinusitis With Nasal Polyps
5